首页> 外文OA文献 >Brown coal derived humate inhibits contact hypersensitivity : an efficacy, toxicity and teratogenicity study in rats
【2h】

Brown coal derived humate inhibits contact hypersensitivity : an efficacy, toxicity and teratogenicity study in rats

机译:褐煤衍生的腐植酸抑制接触性超敏反应:大鼠的功效,毒性和致畸性研究

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

OBJECTIVES:The effects of two humate products were compared to that of prednisolone on a contact hypersensitivity rat model. METHODS: Rats, sensitized with dinitrofluorobenzene (DNFB), were placed on a daily oral treatment of 61mg/kg BW of humate derived from either leonardite or bituminous coal or on prednisolone at one mg/kg BW and challenged 6 days later with a topical application of DNFB to the right ear. The inflamed ears were measured daily. In a toxicity study rats were exposed to daily oral treatment of leonardite humate at 1,000 mg/kg BW for 1 month. A teratogenicity study was done where pregnant rats were treated with 500 mg/kg BW on days 5 to 17 of pregnancy. RESULTS: Only the leonardite humate compared favourably with prednisolone in suppressing contact hypersensitivity. No signs of toxicity were observed and weight gain was normal during the 6-day and 1month treatments and during the teratogenicity study with the leonardite humate. However, the rats on the other two products experienced slower weight gain. CONCLUSION: The identification of a naturally occurring nontoxic compound with anti-inflammatory activity is exciting and merits further evaluation in the treatment of patients suffering from inflammatory conditions.
机译:目的:比较两种腐殖酸盐产品与泼尼松龙在接触性超敏反应大鼠模型中的作用。方法:将对二硝基氟苯(DNFB)致敏的大鼠每日口服治疗61 mg / kg体重的源自雪白石或烟煤的腐殖酸盐,或泼尼松龙以1 mg / kg体重的剂量口服,并于6天后进行局部应用攻击DNFB到右耳。每天测量发炎的耳朵。在一项毒性研究中,大鼠每日以1,000 mg / kg BW的剂量进行过莱诺石腐殖酸盐的口服治疗,持续1个月。进行了致畸性研究,其中在怀孕的第5至17天用500 mg / kg BW治疗了怀孕的大鼠。结果:在抑制接触性超敏反应方面,只有莱纳石腐殖酸盐优于泼尼松龙。在6天和1个月的治疗过程中以及在用莱纳石腐殖酸盐进行致畸性研究期间,未观察到毒性迹象,体重增加正常。但是,使用其他两种产品的大鼠体重增加较慢。结论:鉴定具有抗炎活性的天然无毒化合物是令人兴奋的,应进一步评估其在治疗炎症性疾病患者中的价值。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号